Use Patterns of Long-acting Bronchodilators in Routine COPD Care: The OUTPUL Study

References

• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349(9064):1498–1504.
   PubMed Web of Science ®Google Scholar
• Hanania NA. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm Pharmacol Ther 2008; 21:540–550.
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Aaron S, Bourbeau J, Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J 2007; 14(Suppl B):5B–32B.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176(6):532–555.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agustí AG, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187(4):347–65.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Lofdahl CG, Laitinen LA, Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society study on chronic obstructive pulmonary disease. N Engl J Med 1999; 340:1948–1953.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Sorensen T, Lange P, Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353:1819–1823.
   PubMed Web of Science ®Google Scholar
• Burge PS, Calverley PM, Jones PW, Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Br Med J 2000; 320:1297–1303.
   PubMed Web of Science ®Google Scholar
• Yang IA, Clarke MS, Sim EH, Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012 Jul; 7:CD002991.
   PubMed Web of Science ®Google Scholar
• Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world: effectiveness versus efficacy studies. Pharmacoeconomics 1999; 15:423–434.
   PubMed Web of Science ®Google Scholar
• Rand CS, Nides M, Cowles MK, Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med 1995; 152:580–588.
   PubMed Web of Science ®Google Scholar
• Van Grunsven PM, van Schayck CP, van Deuveren M, Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000; 37:225–234.
   PubMed Web of Science ®Google Scholar
• Kesten S, Flanders J, Serby CW, Compliance with tiotropium, a once daily dry powder inhaled bronchodilator, in one year COPD trials. Chest 2000; 118:191S–192S.
   Google Scholar
• Krigsman K, Nilsson JL, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf 2007; 16:441–448.
   PubMed Web of Science ®Google Scholar
• Dolce JJ, Crisp C, Manzella B, Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99:837–841.
   PubMed Web of Science ®Google Scholar
• Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication. Does combining beta agonists with corticosteroids improve compliance? Eur Respir J 1994; 7:504–509.
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008; 63:831–838.
   PubMed Web of Science ®Google Scholar
• Regueiro CR, Hamel MB, Davis RB, A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. Am J Med 1998; 105:366–372.
   PubMed Web of Science ®Google Scholar
• Osthoff M, Leuppi JD. Management of chronic obstructive pulmonary disease patients after hospitalization for acute exacerbation. Respiration 2010; 79:255–261.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva, World Health Organization, 2003; pp 1–45.
   Google Scholar
• Jochmann A, Neubauer F, Miedinger D, General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly 2010; 140:w13053:1–8; online version: www.smw.ch.
   Google Scholar
• Rutschmann OT, Janssens JP, Vermeulen B, Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004; 98(10):932–937.
   PubMed Web of Science ®Google Scholar
• Foster JA, Yawn BP, Maziar A, Enhancing COPD management in primary care settings. Med Gen Med 2007; 9(3):24.
   PubMedGoogle Scholar
• Kirchmayer U, Agabiti N, Belleudi V, Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy. J Clin Pharm Ther 2012; 37(1):37–44.
   PubMed Web of Science ®Google Scholar
• Fano V, D'Ovidio M, Del Zio K, The role of the quality of Hospital Discharge Records on the comparative evaluation of outcomes: the example of Chronic Obstructive Pulmonary Disease. Epidemiol Prev 2012; 36(3–4):172–179.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Seeger JD, Maclure M, Performance of co-morbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154(9):854–864.
   PubMed Web of Science ®Google Scholar
• World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, 2012.
   Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143(1):29–36.
   PubMed Web of Science ®Google Scholar
• Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38(2):303–312.
   PubMed Web of Science ®Google Scholar
• Takemura M, Mitsui K, Itotani R, Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011; 6:97–104.
   PubMed Web of Science ®Google Scholar
• de Luise C, Lanes SF, Jacobsen J, Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark. Eur J Epidemiol 2007; 22(4):267–72.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363(12):1128–1138.
   PubMed Web of Science ®Google Scholar
• Simoni M, Carrozzi L, Baldacci S, Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples. Respir Med 2008; 102(1):82–91.
   PubMed Web of Science ®Google Scholar